These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21132811)

  • 1. Endogenous dopamine (DA) competes with the binding of a radiolabeled D₃ receptor partial agonist in vivo: a positron emission tomography study.
    Mach RH; Tu Z; Xu J; Li S; Jones LA; Taylor M; Luedtke RR; Derdeyn CP; Perlmutter JS; Mintun MA
    Synapse; 2011 Aug; 65(8):724-32. PubMed ID: 21132811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography imaging of dopamine D2 receptors using a highly selective radiolabeled D2 receptor partial agonist.
    Xu J; Vangveravong S; Li S; Fan J; Jones LA; Cui J; Wang R; Tu Z; Chu W; Perlmutter JS; Mach RH
    Neuroimage; 2013 May; 71():168-74. PubMed ID: 23333701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain uptake and distribution of the dopamine D3 /D2 receptor partial agonist [11 C]cariprazine: an in vivo positron emission tomography study in nonhuman primates.
    Tóth M; Varrone A; Steiger C; Laszlovszky I; Horváth A; Kiss B; Gyertyán I; Adham N; Halldin C; Gulyás B
    Synapse; 2013 May; 67(5):258-64. PubMed ID: 23238770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist.
    Searle G; Beaver JD; Comley RA; Bani M; Tziortzi A; Slifstein M; Mugnaini M; Griffante C; Wilson AA; Merlo-Pich E; Houle S; Gunn R; Rabiner EA; Laruelle M
    Biol Psychiatry; 2010 Aug; 68(4):392-9. PubMed ID: 20599188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D3 receptor binding of (18)F-fallypride: Evaluation using in vitro and in vivo PET imaging studies.
    Mukherjee J; Constantinescu CC; Hoang AT; Jerjian T; Majji D; Pan ML
    Synapse; 2015 Dec; 69(12):577-91. PubMed ID: 26422464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, radiolabeling, and in vivo evaluation of carbon-11 labeled N-[2-[4-(3-cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a potential positron emission tomography tracer for the dopamine D(4) receptors.
    Lacivita E; De Giorgio P; Lee IT; Rodeheaver SI; Weiss BA; Fracasso C; Caccia S; Berardi F; Perrone R; Zhang MR; Maeda J; Higuchi M; Suhara T; Schetz JA; Leopoldo M
    J Med Chem; 2010 Oct; 53(20):7344-55. PubMed ID: 20873719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon-11 pb-12: an attempt to visualize the dopamine d(4) receptor in the primate brain with positron emission tomography.
    Langer O; Halldin C; Chou Y; Sandell J; Swahn C; Någren K; Perrone R; Berardi F; Leopoldo M; Farde L
    Nucl Med Biol; 2000 Nov; 27(8):707-14. PubMed ID: 11150701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal and extrastriatal microPET imaging of D2/D3 dopamine receptors in rat brain with [¹⁸F]fallypride and [¹⁸F]desmethoxyfallypride.
    Constantinescu CC; Coleman RA; Pan ML; Mukherjee J
    Synapse; 2011 Aug; 65(8):778-87. PubMed ID: 21218455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of fluorine-18-labeled SA4503 as a selective sigma1 receptor ligand for positron emission tomography.
    Kawamura K; Tsukada H; Shiba K; Tsuji C; Harada N; Kimura Y; Ishiwata K
    Nucl Med Biol; 2007 Jul; 34(5):571-7. PubMed ID: 17591557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization, and monkey positron emission tomography (PET) studies of [18F]Y1-973, a PET tracer for the neuropeptide Y Y1 receptor.
    Hostetler ED; Sanabria-Bohórquez S; Fan H; Zeng Z; Gantert L; Williams M; Miller P; O'Malley S; Kameda M; Ando M; Sato N; Ozaki S; Tokita S; Ohta H; Williams D; Sur C; Cook JJ; Burns HD; Hargreaves R
    Neuroimage; 2011 Feb; 54(4):2635-42. PubMed ID: 21078401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of [(18)F]-(-)-norchlorofluorohomoepibatidine ([(18)F]-(-)-NCFHEB) as a PET radioligand to image the nicotinic acetylcholine receptors in non-human primates.
    Bois F; Gallezot JD; Zheng MQ; Lin SF; Esterlis I; Cosgrove KP; Carson RE; Huang Y
    Nucl Med Biol; 2015 Jun; 42(6):570-7. PubMed ID: 25858513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marmoset Serotonin 5-HT1A Receptor Mapping with a Biased Agonist PET Probe 18F-F13714: Comparison with an Antagonist Tracer 18F-MPPF in Awake and Anesthetized States.
    Yokoyama C; Mawatari A; Kawasaki A; Takeda C; Onoe K; Doi H; Newman-Tancredi A; Zimmer L; Onoe H
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27608810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
    Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
    Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in dopamine release and dopamine D2/3 receptor levels with the development of mild obesity.
    Kessler RM; Zald DH; Ansari MS; Li R; Cowan RL
    Synapse; 2014 Jul; 68(7):317-20. PubMed ID: 24573975
    [No Abstract]   [Full Text] [Related]  

  • 15. Endogenous competition against binding of [(18)F]DMFP and [(18)F]fallypride to dopamine D(2/3) receptors in brain of living mouse.
    Rominger A; Wagner E; Mille E; Böning G; Esmaeilzadeh M; Wängler B; Gildehaus FJ; Nowak S; Bruche A; Tatsch K; Bartenstein P; Cumming P
    Synapse; 2010 Apr; 64(4):313-22. PubMed ID: 19957365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.
    Stehouwer JS; Daniel LM; Chen P; Voll RJ; Williams L; Plott SJ; Votaw JR; Owens MJ; Howell L; Goodman MM
    J Med Chem; 2010 Aug; 53(15):5549-57. PubMed ID: 20597489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol.
    Vandehey NT; Moirano JM; Converse AK; Holden JE; Mukherjee J; Murali D; Nickles RJ; Davidson RJ; Schneider ML; Christian BT
    J Cereb Blood Flow Metab; 2010 May; 30(5):994-1007. PubMed ID: 20040928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (-)-[(18) F]Flubatine: evaluation in rhesus monkeys and a report of the first fully automated radiosynthesis validated for clinical use.
    Hockley BG; Stewart MN; Sherman P; Quesada C; Kilbourn MR; Albin RL; Scott PJ
    J Labelled Comp Radiopharm; 2013 Oct; 56(12):595-9. PubMed ID: 24285235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the effect of endogenous dopamine on baseline [(11) C]-(+)-PHNO binding in the human brain.
    Caravaggio F; Kegeles LS; Wilson AA; Remington G; Borlido C; Mamo DC; Graff-Guerrero A
    Synapse; 2016 Nov; 70(11):453-60. PubMed ID: 27341789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surrogate markers for cerebral blood flow correlate with [¹⁸F]-fallypride binding potential at dopamine D(2/3) receptors in human striatum.
    Cumming P; Xiong G; la Fougère C; Rominger A; Bartenstein P; Buchholz HG; Piel M; Rösch F; Gründer G; Vernaleken I
    Synapse; 2013 Apr; 67(4):199-203. PubMed ID: 23239525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.